Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
Date:8/6/2009

Six months Six months ended ended Jun 30, 2009 Jun 30, 2008 ---------------------------- Stock-based compensation $ (592) $ (924) Termination and reorganization costs (1,266) (2,755) Litigation expenses (2,241) (2,289) Non-recurring transaction fees, and supply/distribution agreement termination costs (1,032) (751) --------------------------------------------------------------------- $ (5,131) $ (6,718) ---------------------------- e. Amortization of acquisition related intangible assets and medical technologies. f. Non-recurring in-process research and development expense relating to payments made to licensors and collaborators. g. Foreign exchange fluctuations on foreign currency net monetary assets. h. Loss on write-down of deferred financing charges and realized loss on disposition of capital assets. i. Loss on write-down of investments related to two available-for-sale equity securities that had been trading below carrying value for a prolonged period of time. j. Amortization of deferred financing costs. k. Tax effects of adjustments a. through j. for the period. ANGIOTECH PHARMARCEUTICALS, INC. CALCULATION OF ADJUSTED EBITDA (unaudited) Three months Six months (in thousands ended June 30, ended Jun
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Marktech Optoelectronics has introduced ... violet emitters in the 280 nm wavelength range. This ... which range from 280nm to 405nm. These new devices ... as well as curing. Mark Campito, Marktech’s CEO states ... interest to manufacturers is that we offer it in ...
(Date:9/22/2014)... who were treated with a statin in the hospital ... likely to survive than those who were not, according ... . This study was conducted by the same researchers ... can improve survival in victims of ischemic stroke., Ischemic ... a blood vessel that blocks blood from reaching areas ...
(Date:9/22/2014)... cell fragments whose job it is to stop bleeding, ... But they can "feel" the physical environment around them, ... Platelets respond to surfaces with greater stiffness by increasing ... other platelets and other components of the clotting system, ... give them credit for, in that they are able ...
(Date:9/22/2014)... Lawrence Livermore National Laboratory Director Bill ... renewed their institutional commitment by signing a memorandum ... expand the collaborative work in the areas of ... and environmental sciences. , This renewal represents a ... December 2009 and is a framework to broaden ...
Breaking Biology Technology:Marktech Introduces its New Line of Deep UV Emitters 2Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2Platelets modulate clotting behavior by 'feeling' their surroundings 2Lawrence Livermore Renews Pact with Georgetown University to Expand Research and Education in Science and Policy 2
... Oconomowoc-based IT services provider, announced Tuesday a new market ... July 1, the campaign will expand the PDS presence ... recently received Specialized Technology Partner Certifications from Cisco in ... partner; IP Communications, IP Communications Express, and Wireless. In ...
... When Hurricane Dennis reached landfall in the Florida ... surprising a development. Weather Central Inc. , a ... almost the exact location two days earlier. , ,On ... a service used by more than 100 television stations ...
... incubates a branding process, which can result in a random ... extreme name identity, whereupon a major advertising process kicks in. ... that's how we refer to today's trendy branding. To avoid ... various branding tricks and become aware of the bigger risks. ...
Cached Biology Technology:Accidental naming 2Accidental naming 3Accidental naming 4
(Date:9/23/2014)... California , 23 de septiembre de ... lanzamiento del Sistema 1290 Infinity II LC, ... de Infinity en su portafolio de cromatografía ... científicos y directores de laboratorio que alcancen ... excepcional, facilidad de uso y capacidad de ...
(Date:9/22/2014)... A new American Cancer Society study suggests that ... previously known as the food stamp program, had ... non-participants. The authors say the findings emphasize the ... dietary quality of SNAP participants. , The SNAP ... with the resources to obtain a nutritionally adequate ...
(Date:9/22/2014)... also known as tapioca, has large starch-filled roots and ... Asia, and Latin America where corn and sugarcane are ... and processes designed to break down tapioca starch into ... such as glucose, fructose, or maltose syrup, tapioca may ... a Review article in Industrial Biotechnology , a ...
Breaking Biology News(10 mins):Agilent Technologies anuncia el lanzamiento del Sistema 1290 Infinity II LC 2Agilent Technologies anuncia el lanzamiento del Sistema 1290 Infinity II LC 3Federal food program puts food on the table, but dietary quality could be improved 2
... menstruating have a weakening in the quality of their bone ... getting plenty of weight-bearing exercise, a new study finds. The ... Annual Meeting in Boston. "Given the high number of ... fact that up to 24% of young female athletes may ...
... Using the only microscope of its kind in Australia, ... see the inner workings of T-cells, the front-line troops that ... germs and other invaders in our bloodstream. The discovery ... T-cells into action a breakthrough that could lead to ...
... 2011 The International Development Research Centre (IDRC) together with ... Sciences and Engineering Research Council of Canada (NSERC), and ... (SSHRC) today announce that five research teams have been ... International Research Initiative on Adaptation to Climate Change (IRIACC). ...
Cached Biology News:Athletic girls more likely to have impaired bone structure if menstrual cycle stops 2Scientists use super microscope to pinpoint body’s immunity 'switch' 2International research initiative on adaptation to climate change announces research awards 2International research initiative on adaptation to climate change announces research awards 3
ANXA11 Immunogen: ANXA11 (NP_001148, 406 a.a. ~ 506 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Anti-ADAM-12 (Meltrin Alpha); carboxy terminal end; rabbit host...
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C...
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
Biology Products: